{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:09:41Z","timestamp":1778854181073,"version":"3.51.4"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360513"],"award-info":[{"award-number":["82360513"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20224ACB206037"],"award-info":[{"award-number":["20224ACB206037"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.rmcr.2026.102367","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:31:18Z","timestamp":1768350678000},"page":"102367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Disseminated tuberculosis secondary to polymicrobial co-infection following long-term immunotherapy for sarcomatoid mesothelioma: A case report"],"prefix":"10.1016","volume":"59","author":[{"given":"Lingyin","family":"Xia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianning","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeqing","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.rmcr.2026.102367_bib1","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMra1912719","article-title":"Perspectives on the treatment of malignant pleural mesothelioma","volume":"385","author":"Janes","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"10026","key":"10.1016\/j.rmcr.2026.102367_bib2","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","article-title":"Bevacizumab for newly diagnosed pleural mesothelioma in the mesothelioma avastin cisplatin pemetrexed study (MAPS): a randomised, controlled, open-label, phase 3 trial","volume":"387","author":"Zalcman","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.rmcr.2026.102367_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nri.2017.108","article-title":"The diverse functions of the PD1 inhibitory pathway","volume":"18","author":"Sharpe","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"10272","key":"10.1016\/j.rmcr.2026.102367_bib4","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(20)32714-8","article-title":"First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial","volume":"397","author":"Baas","year":"2021","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.rmcr.2026.102367_bib5","doi-asserted-by":"crossref","first-page":"e1302","DOI":"10.1093\/cid\/ciaa1189","article-title":"Immunosuppressive agents and infectious risk in transplantation: managing the \"Net State of Immunosuppression\"","volume":"73","author":"Roberts","year":"2021","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.rmcr.2026.102367_bib6","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/thoraxjnl-2021-217260","article-title":"Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy","volume":"77","author":"Morelli","year":"2022","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.rmcr.2026.102367_bib7","first-page":"423","article-title":"Tuberculosis diagnostics: overcoming ancient challenges with modern solutions","volume":"4","author":"MacGregor-Fairlie","year":"2020","journal-title":"Emerg Top Life Sci"},{"issue":"4","key":"10.1016\/j.rmcr.2026.102367_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2020-000866","article-title":"Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitors","volume":"5","author":"Anand","year":"2020","journal-title":"ESMO Open"},{"issue":"3","key":"10.1016\/j.rmcr.2026.102367_bib9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.resinv.2024.02.002","article-title":"Cancer immunotherapy with immune checkpoint inhibitors and infections: a particular focus on mycobacterial infections","volume":"62","author":"Fujita","year":"2024","journal-title":"Respir Investig."},{"issue":"6","key":"10.1016\/j.rmcr.2026.102367_bib10","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1469-0691.2009.02939.x","article-title":"Mycobacterial bacteraemia in patients infected and not infected with human immunodeficiency virus, Taiwan","volume":"16","author":"Tan","year":"2010","journal-title":"Clin. Microbiol. Infect."},{"issue":"3","key":"10.1016\/j.rmcr.2026.102367_bib12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3892\/mmr.2024.13277","article-title":"Clinical diagnostic value of targeted next-generation sequencing for infectious diseases","volume":"30","author":"Chen","year":"2024","journal-title":"Mol. Med. Rep."},{"issue":"8","key":"10.1016\/j.rmcr.2026.102367_bib14","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1001\/archinte.144.8.1667","article-title":"Rifampin drug interactions","volume":"144","author":"Baciewicz","year":"1984","journal-title":"Arch. Intern. Med."},{"issue":"9","key":"10.1016\/j.rmcr.2026.102367_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-233678","article-title":"Nocardia farcinica masquerading as intracerebral metastases in advanced metastatic prostatic cancer","volume":"13","author":"Livings","year":"2020","journal-title":"BMJ Case Rep."},{"issue":"1","key":"10.1016\/j.rmcr.2026.102367_bib16","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12879-024-09031-7","article-title":"A regimen based on the combination of trimethoprim\/sulfamethoxazole with caspofungin and corticosteroids as a first-line therapy for patients with severe non-HIV-related pneumocystis jirovecii pneumonia: a retrospective study in a tertiary hospital","volume":"24","author":"Li","year":"2024","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"10.1016\/j.rmcr.2026.102367_bib17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12879-016-2097-7","article-title":"Concomitant disseminated histoplasmosis and disseminated tuberculosis after tumor necrosis factor inhibitor treatment: a case report","volume":"17","author":"Mu\u00f1oz-Oca","year":"2017","journal-title":"BMC Infect. Dis."},{"issue":"11","key":"10.1016\/j.rmcr.2026.102367_bib18","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1007\/s00262-022-03198-1","article-title":"Serial interferon-gamma release assay in lung cancer patients receiving immune checkpoint inhibitors: a prospective cohort study","volume":"71","author":"Fujita","year":"2022","journal-title":"Cancer Immunol. Immunother."}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007126000043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007126000043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:29:34Z","timestamp":1778851774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213007126000043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":16,"alternative-id":["S2213007126000043"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2026.102367","relation":{},"ISSN":["2213-0071"],"issn-type":[{"value":"2213-0071","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disseminated tuberculosis secondary to polymicrobial co-infection following long-term immunotherapy for sarcomatoid mesothelioma: A case report","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2026.102367","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102367"}}